Cargando…
No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial
BACKGROUND: The widespread use of natural health products is also a problem, as they could interact with prescribed drugs in patients. One commonly used product is glucosamine for osteoarthritis and some reports have found increased values of cholesterol and other lipids in patients treated with sim...
Autores principales: | Eggertsen, Robert, Andreasson, Åke, Andrén, Lennart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517750/ https://www.ncbi.nlm.nih.gov/pubmed/23050945 http://dx.doi.org/10.1186/2050-6511-13-10 |
Ejemplares similares
-
Abnormally High Content of Free Glucosamine Residues
Identified in a Preparation of Commercially Available Porcine Intestinal
Heparan Sulfate
por: Mulloy, Barbara, et al.
Publicado: (2016) -
Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012) -
Commercially available accelerators
por: Barbalat, Oscar
Publicado: (1996) -
Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature()
por: Lopes Júnior, Osmar Valadão, et al.
Publicado: (2013) -
Tracking human interactions with a commercially-available robot over multiple days
por: Hortensius, Ruud, et al.
Publicado: (2022)